Drug Markets/Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate

Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate

1 NDC across 1 manufacturer|0 Generic,1 Brand

▸ More about this market

Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $150.14 to $150.14 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$150.14 – $150.14

per EA

7d Activity

5↑-4 flat

avg +0.3% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE

Frequently Asked Questions

How many Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate products are on the market?

The Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate?

NADAC reference prices for Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate range from $150.1432 to $150.1432 per EA.

Which manufacturers make Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate?

1 manufacturer lists Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate in NADAC. Ranked by number of NDCs, the largest are Gilead Sciences, Inc. (1).

How has the price of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate changed recently?

Over the past 7 days, 5 Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate NDCs rose and 0 fell, with a market-wide average change of +0.3%.